Cobenfy, a schizophrenia drug, shows promise in treating Alzheimer’s disease.
Bristol Myers Squibb Believes Alzheimer’s is Largest Market for Schizophrenia Drug Cobenfy Bristol Myers Squibb believes that Alzheimer’s disease is the largest…
Bristol Myers Squibb Believes Alzheimer’s is Largest Market for Schizophrenia Drug Cobenfy Bristol Myers Squibb believes that Alzheimer’s disease is the largest…